Literature DB >> 11143884

Addressing ethical issues in geriatrics and long-term care: ethics education at the Baycrest Centre for Geriatric Care.

M Gordon1, L Turner, E Bourret.   

Abstract

An innovative program in ethics education exists at Baycrest Centre for Geriatric Care. This program can serve as a helpful model for long-term care and geriatric care facilities seeking to implement formal training programs in bioethics. Various aspects of the ethics education program are examined. In addition to describing the role of the ethics committee and research ethics board, consideration is given to case consultations, ethics rounds, the training of junior physicians and medical students, grand rounds and the planning of conferences and guest lectures. With regard to educational content in bioethics, health law, professional guidelines and the principlist approach of Beauchamp and Childress are used to explore the ethical dimensions of particular cases. Given the clinical context of the educational initiatives, the pedagogical approach is predominately case-based. While the bioethics literature emphasizes the patient-physician relationship, ethics education at Baycrest recognizes the importance of multiple professions. Physicians, nurses, social workers, speech pathologists, nutritionists and other health care providers are involved in ethical deliberation and education.

Entities:  

Keywords:  Bioethics and Professional Ethics; Professional Patient Relationship

Mesh:

Year:  2000        PMID: 11143884

Source DB:  PubMed          Journal:  Med Law        ISSN: 0723-1393


  2 in total

1.  Predictors of ethical stress, moral action and job satisfaction in health care social workers.

Authors:  Patricia O'Donnell; Adrienne Farrar; Karlynn BrintzenhofeSzoc; Ann Patrick Conrad; Marion Danis; Christine Grady; Carol Taylor; Connie M Ulrich
Journal:  Soc Work Health Care       Date:  2008

Review 2.  Ethical challenges in end-of-life therapies in the elderly.

Authors:  Michael Gordon
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.